- Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
- Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
- Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
- Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
Nanopore sequencing to reveal the origins of circulating immune DNA in cancer: presentation
- Share
- Tweet
- Share on Facebook
- Share
Presentation title: “Nanopore sequencing to reveal the origins of circulating immune DNA in cancer.”
Presented at CNAPS 2024
Presented by Ben Berman, PhD, Principal Bioinformatician, Volition, Associate Professor, Hebrew University of Jerusalem
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields